Lv01
0 积分 2022-02-14 加入
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
5小时前
已完结
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
19天前
已完结
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma
22天前
已完结
Targeted Treatments for Myasthenia Gravis in Children and Adolescents
1个月前
已完结
Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study
4个月前
已完结
皖公网安备34019202002308
